Properties (60)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:aimsTo |
improve_global_health
|
gptkbp:collaboratesWith |
government agencies
academic institutions |
gptkbp:conducts |
clinical research
|
gptkbp:develops |
vaccines
antiviral therapies |
gptkbp:employs |
researchers
scientists |
gptkbp:focusesOn |
infectious diseases
|
gptkbp:hasCollaboratedWith |
gptkb:CDC
WHO |
gptkbp:hasDeveloped |
gptkb:COVID-19_vaccine
HIV treatment tuberculosis treatment antibiotic treatments |
gptkbp:hasEstablished |
research collaborations
|
gptkbp:hasHistoricalSignificance |
gptkb:Beerse,_Belgium
|
gptkbp:hasLocalCuisine |
various countries
|
gptkbp:hasParticipatedIn |
over 150 countries
|
gptkbp:hasPartnershipsWith |
non-profit organizations
healthcare_providers |
gptkbp:hasResearchInterest |
gptkb:COVID-19
HIV tuberculosis |
gptkbp:hasResidence |
government grants
private investors |
https://www.w3.org/2000/01/rdf-schema#label |
Janssen Infectious Diseases
|
gptkbp:isActiveIn |
vaccine distribution
clinical research trials |
gptkbp:isDedicatedTo |
patient care
advancing medical science |
gptkbp:isEngagedIn |
community outreach
biomedical research therapeutic development |
gptkbp:isFocusedOn |
disease prevention
vaccine development global health challenges patient-centered solutions |
gptkbp:isInvolvedIn |
educational programs
public health initiatives global health security vaccine research infectious disease prevention healthcare_innovation healthcare_partnerships |
gptkbp:isKnownFor |
research and development
collaborative research efforts innovative treatments clinical excellence |
gptkbp:isPartOf |
gptkb:Johnson_&_Johnson's_pharmaceutical_segment
biopharmaceutical industry Johnson_&_Johnson's_global_health_strategy Johnson_&_Johnson's_commitment_to_health |
gptkbp:isRecognizedFor |
scientific contributions
innovation in healthcare public health impact |
gptkbp:offers |
clinical trials
|
gptkbp:partOf |
gptkb:Johnson_&_Johnson
|
gptkbp:wasFoundedIn |
2009
|